IRON Investors Have Opportunity to Join Disc Medicine, Inc. Fraud Investigation with the Schall Law Firm
Disc Medicine, Inc. (IRON)
Company Research
Source: Business Wire
LOS ANGELES--(BUSINESS WIRE)--The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Disc Medicine, Inc. (“Disc” or “the Company”) (NASDAQ: IRON) for violations of the securities laws.The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Disc is the subject of a Reuters report published on January 15, 2026. According to the report, the Company suffered a delay in its experimental drug’s review timeline "after [U.S. Food and Drug Administration] scientists flagged safety and efficacy concerns." Based on this news, shares of Disc fell by more than 7.8% on the same day.If you are a shareholder who suffered a loss, click here to participate.We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights f
Show less
Read more
Impact Snapshot
Event Time:
IRON
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IRON alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IRON alerts
High impacting Disc Medicine, Inc. news events
Weekly update
A roundup of the hottest topics
IRON
News
- IRON Drops Up to 39% After FDA CRL for Bitopertin -- LEVI & KORSINSKY, LLP InvestigatesGlobeNewswire
- IRON Investors Lose Up to $22/Share -- LEVI & KORSINSKY, LLP Investigates Disc MedicinePR Newswire
- Evaluating Disc Medicine (IRON) After Recent Share Moves And Conflicting Valuation Signals [Yahoo! Finance]Yahoo! Finance
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc. - IRONGlobeNewswire
- Disc Medicine (IRON) had its price target raised by Wells Fargo & Company from $78.00 to $79.00. They now have an "overweight" rating on the stock.MarketBeat
IRON
Earnings
- 2/26/26 - Miss
IRON
Sec Filings
- 3/4/26 - Form 4
- 3/2/26 - Form 144
- 2/27/26 - Form 4
- IRON's page on the SEC website